Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537350 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato
A NA study of Skin, sponsored by LycoRed.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT05537350: Completed NA study of Skin, sponsored by LycoRed.
NCT05537350 is a NA study of Skin that has completed, run by LycoRed. The registered enrollment target is 66 participants, above the 54-participant average among 5 other Skin trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05537350, a NA study of Skin, has completed, sponsored by LycoRed.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects will be enrolled in this clinical study to assess the efficacy of an oral supplement to change the characteristics of facial skin after 4 and 12 weeks of use and obtain consumer perception of the test product through the use of questionnaires. Study evaluations will include a comprehensive metabolic panel, Cutometer measurements, Canfield's VISIA-CR images, VapoMeter Measurements, and Consumer perception questionnaires.
Primary Outcome
VapoMeter Measurements before and after treatment FaceQ questionnaire before and after treatment
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Lumenato
Study Locations (1)
New Jersey
- Eurofins | CRL, Inc. - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
What the finished NCT05537350 record still lists
NCT05537350 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, above the 54-participant average among 5 other Skin trials with a reported enrollment target (22% higher).
The record links to 1 condition, with Skin appearing as the primary indexed condition, and to 1 intervention - of which Lumenato is the first listed.
NCT05537350 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05537350 about?
NCT05537350 is a clinical study titled "A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato". Subjects will be enrolled in this clinical study to assess the efficacy of an oral supplement to change the characteristics of facial skin after 4 and 12 weeks of use and obtain consumer perception of the test product through the use of questionnaires. Study evaluations will include a comprehensive...
What is the current status of trial NCT05537350?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2022-01-04. Estimated completion is 2022-08-31.
What conditions does trial NCT05537350 study?
This clinical trial studies the following conditions: Skin.
What interventions are being tested in trial NCT05537350?
The interventions under investigation include: Lumenato (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05537350?
This trial is sponsored by LycoRed, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05537350 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
See the Impact Beem's Blue Light Therapy Has on Your Skin Health!
RECRUITING · NA
-
Lumenato Nutritional Supplement on Skin Appearance
COMPLETED · NA
-
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
COMPLETED · NA
-
Trial of Ixazomib for Kaposi Sarcoma
RECRUITING · Phase 2
-
In Vivo Cross-Modal Imaging of Skin
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI